News Snapshot:
0 Authorities in Brazil have released the long-anticipated results for a Chinese-developed COVID-19 vaccine trial in the South American country, saying it appears to be 78% effective in preventing the disease. Dimas Covas, director of the Butantan Institute in São Paulo, which conducted the clinical trial, also said during a press conference Thursday that the vaccine developed by Chinese pharmaceutical giant Sinovac can prevent severe cases of COVID-19 from developing 100% of the time. The vaccine, dubbed CoronaVac, is the second Chinese coronavirus vaccine shown to be effective in large-scale human trials. Last week, another Chinese pharmaceutical company, Sinopharm, said...
